Clinical Trials

At The Skin Hospital we are committed to advancing the treatments and cures for skin diseases. Clinical Trials form a vital part of this process and are essential for the development of innovative and life changing medicine.
Clinical Trial – Atopic Dermatitis (Eczema)2019-02-27T15:52:09+00:00

Atopic Dermatitis (Eczema)

If you suffer from mild, moderate, or severe eczema, you may be eligible for participating in one of the eczema clinical trials at The Skin Hospital.


Trial 1: Tralokinumab (injection)

Participants: Aged 12-18 years old with moderate to severe eczema (atopic dermatitis)

Status: Currently recruiting at Darlinghurst

More information: https://clinicaltrials.gov/ct2/show/NCT03526861


Trial 2: Baricitnib (oral tablet) and topical corticosteriod treatment

Participants: Adults with moderate to severe eczema (atopic dermatitis)

Status: Currently recruiting at Darlinghurst

More information: https://clinicaltrials.gov/ct2/show/NCT0373330


Trial 3: Cannabidiol (topical cream, steroid free) treatment

Participants: Aged 12–70 years old with moderate eczema (atopic dermatitis)

Status: Currently recruiting at Westmead site

More information: Link will be added after the trial is registered at http://www.anzctr.org.au/


Trial 4: PF-04965842 (oral tablet) treatment

Participants: Aged 12–18 years of age with moderate to severe eczema (atopic dermatitis)

Status: Recruiting soon at Westmead site. Please register your interest.

More information: Link will be added after the trial is registered at http://www.anzctr.org.au/


Trial 5: Baricitnib (oral tablet) treatment

Participants: Adults with moderate to severe eczema (atopic dermatitis)

Status: Active not recruiting at Westmead

More information: https://clinicaltrials.gov/ct2/show/NCT03334422


Trial 6: Trial 5 extension study for Baricitnib treatment

Paticipants: Adults with moderate to severe eczema (atopic dermatitis)

Status: Active not recruiting at Westmead

More information: https://clinicaltrials.gov/ct2/show/NCT03334422


Trial 7: Tralokinumab monotherapy (injection)

Participants: Aged 18 years or older with moderate to severe eczema (atopic dermatitis)

Status: Active not recruiting at Darlinghurst

More information: https://clinicaltrials.gov/ct2/show/NCT03160885

MENU